AWS launched managed OpenClaw on Lightsail for AI agent deployment while security concerns mount. The 250k-star GitHub project is affected by CVE-2026-25253, which enables one-click RCE, with 17,500+ ...

The beauty of pattern-based learning is its transferability. Once you grasp the core idea behind, say, the "Two Pointers" technique, you can apply it to a range of problems, from finding pairs that ...

The first time that University of Oxford astronomer Lyla Jung saw the cosmic configuration on her monitor, she almost didn’t believe it was real. But it was—and Jung and her colleagues went on to ...

Ancient civilizations accomplished feats of engineering that continue to challenge modern understanding. Despite advances in archaeology, materials science, and experimental reconstruction, several ...

We introduce VeriStruct, a novel framework that extends AI-assisted automated verification from single functions to more complex data structure modules in Verus. VeriStruct employs a planner module to ...

The U.S. Senate negotiations over a crypto market structure bill — the industry's top goal in its policy lobbying — hasn't yet resolved several disagreements as the talks drift toward the holiday ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Shipping-container-based data centers have been introduced as building blocks for constructing mega-data centers. However, it is a challenge on how to interconnect those containers together with ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...